Search research articles
Contact Us
Filters
Showing results (221-230 of 242) with videos related to
Page
of 25
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
August 17, 2020
Radiation Fractionation Schedules Published During the COVID-19 Pandemic: A Systematic Review of the Quality of Evidence and Recommendations for Future Development
David J Thomson, Sue S Yom, Hina Saeed, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 16, 2025
Patient- and clinician-assessed five-year normal tissue effects following one-week versus three-week axillary radiotherapy for breast cancer: Results from the phase III FAST-Forward trial randomised nodal sub-study
A Murray Brunt, Fay H Cafferty, Duncan Wheatley, et al.
Lancet (London, England)
|
June 26, 2020
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial
Adrian Murray Brunt, Joanne S Haviland, Duncan A Wheatley, et al.
Health Technology Assessment (Winchester, England)
|
November 22, 2023
One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT
Adrian Murray Brunt, Joanne S Haviland, Duncan A Wheatley, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 10, 2024
EUSOMA quality indicators for non-metastatic breast cancer: An update
Isabel T Rubio, Lorenza Marotti, Laura Biganzoli, et al.
Breast (Edinburgh, Scotland)
|
March 29, 2020
The requirements of a specialist breast centre
Laura Biganzoli, Fatima Cardoso, Marc Beishon, et al.
Poultry Science
|
August 4, 2023
Isolation, characterization, and experimental infection of Streptococcus gallolyticus subspecies pasteurianus from commercial turkeys with acute septicemia: a pilot study
L S Gray, J D Latorre, D Hernandez-Patlan, et al.
The Lancet. Oncology
|
May 14, 2026
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 10-year efficacy and late normal tissue effects from a multicentre, open-label, non-inferiority, phase 3, randomised controlled trial and 5-year efficacy results from a randomised axillary substudy
Adrian Murray Brunt, Fay H Cafferty, Anna M Kirby, et al.
Critical Reviews in Oncology/Hematology
|
June 8, 2021
The use of bolus in postmastectomy radiation therapy for breast cancer: A systematic review
Hannah M Dahn, Liesbeth J Boersma, Dirk de Ruysscher, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 21, 2019
ESTRO ACROP consensus guideline for target volume delineation in the setting of postmastectomy radiation therapy after implant-based immediate reconstruction for early stage breast cancer
Orit Kaidar-Person, Birgitte Vrou Offersen, Sandra Hol, et al.
Page
of 25
Search research articles
Search
Showing results (221-230 of 242) with videos related to
Sort By:
Page
of 25
International Journal of Radiation Oncology, Biology, Physics
|
August 17, 2020
Radiation Fractionation Schedules Published During the COVID-19 Pandemic: A Systematic Review of the Quality of Evidence and Recommendations for Future Development
David J Thomson, Sue S Yom, Hina Saeed, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 16, 2025
Patient- and clinician-assessed five-year normal tissue effects following one-week versus three-week axillary radiotherapy for breast cancer: Results from the phase III FAST-Forward trial randomised nodal sub-study
A Murray Brunt, Fay H Cafferty, Duncan Wheatley, et al.
Lancet (London, England)
|
June 26, 2020
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial
Adrian Murray Brunt, Joanne S Haviland, Duncan A Wheatley, et al.
Health Technology Assessment (Winchester, England)
|
November 22, 2023
One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT
Adrian Murray Brunt, Joanne S Haviland, Duncan A Wheatley, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 10, 2024
EUSOMA quality indicators for non-metastatic breast cancer: An update
Isabel T Rubio, Lorenza Marotti, Laura Biganzoli, et al.
Breast (Edinburgh, Scotland)
|
March 29, 2020
The requirements of a specialist breast centre
Laura Biganzoli, Fatima Cardoso, Marc Beishon, et al.
Poultry Science
|
August 4, 2023
Isolation, characterization, and experimental infection of Streptococcus gallolyticus subspecies pasteurianus from commercial turkeys with acute septicemia: a pilot study
L S Gray, J D Latorre, D Hernandez-Patlan, et al.
The Lancet. Oncology
|
May 14, 2026
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 10-year efficacy and late normal tissue effects from a multicentre, open-label, non-inferiority, phase 3, randomised controlled trial and 5-year efficacy results from a randomised axillary substudy
Adrian Murray Brunt, Fay H Cafferty, Anna M Kirby, et al.
Critical Reviews in Oncology/Hematology
|
June 8, 2021
The use of bolus in postmastectomy radiation therapy for breast cancer: A systematic review
Hannah M Dahn, Liesbeth J Boersma, Dirk de Ruysscher, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 21, 2019
ESTRO ACROP consensus guideline for target volume delineation in the setting of postmastectomy radiation therapy after implant-based immediate reconstruction for early stage breast cancer
Orit Kaidar-Person, Birgitte Vrou Offersen, Sandra Hol, et al.
Page
of 25